Login / Signup

Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial.

Klaus StahlPhilipp WandBenjamin SeeligerPedro David Wendel-GarciaJulius J SchmidtBernhard M W SchmidtAndrea SauerFelix LehmannUlrich BuddeMarkus BuschOlaf WiesnerTobias WelteHermann HallerHeiner WedemeyerChristian PutensenMarius M HoeperChristian BodeSascha David
Published in: Critical care (London, England) (2022)
Adjunctive TPE is associated with the removal of injurious mediators and repletion of consumed protective factors altogether leading to preserved hemodynamic stabilization in refractory septic shock. We identified that baseline lactate concentration as a potential response predictor might guide future designing of large RCTs that will further evaluate TPE with regard to hard endpoints. Trial registration Retrospectively registered 18th January 2020 at clinicaltrials.gov (Identifier: NCT04231994 ).
Keyphrases
  • septic shock
  • phase iii
  • clinical trial
  • current status
  • phase ii
  • randomized controlled trial
  • human health